Xianghou Xia

1.5k total citations
17 papers, 317 citations indexed

About

Xianghou Xia is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Xianghou Xia has authored 17 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Xianghou Xia's work include RNA modifications and cancer (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Ferroptosis and cancer prognosis (3 papers). Xianghou Xia is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Ferroptosis and cancer prognosis (3 papers). Xianghou Xia collaborates with scholars based in China, Taiwan and Germany. Xianghou Xia's co-authors include Xingfei Yu, Hongjian Yang, Yabing Zheng, Xiangming He, Wenjuan Yin, Yang Yu, Li‐Qiang Qin, Zhongxiao Wan, Shufen Han and Zhiqiang Lin and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Frontiers in Immunology.

In The Last Decade

Xianghou Xia

17 papers receiving 313 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xianghou Xia 134 96 75 58 31 17 317
Geriolda Topi 110 0.8× 99 1.0× 61 0.8× 97 1.7× 39 1.3× 14 320
Yunhua Lin 209 1.6× 122 1.3× 132 1.8× 35 0.6× 30 1.0× 29 415
Shu Tan 154 1.1× 124 1.3× 68 0.9× 171 2.9× 16 0.5× 10 404
Tai Ren 113 0.8× 84 0.9× 56 0.7× 29 0.5× 23 0.7× 29 294
Christopher Hillard 122 0.9× 86 0.9× 66 0.9× 41 0.7× 20 0.6× 8 384
Canqiao Luo 83 0.6× 60 0.6× 37 0.5× 134 2.3× 35 1.1× 13 374
Andrew Becker 165 1.2× 199 2.1× 109 1.5× 33 0.6× 15 0.5× 24 430
Liangliang Sun 148 1.1× 83 0.9× 54 0.7× 46 0.8× 22 0.7× 27 314
Yuying Kou 191 1.4× 48 0.5× 47 0.6× 74 1.3× 14 0.5× 21 300
Hillary Dinh 82 0.6× 65 0.7× 27 0.4× 47 0.8× 38 1.2× 11 462

Countries citing papers authored by Xianghou Xia

Since Specialization
Citations

This map shows the geographic impact of Xianghou Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianghou Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianghou Xia more than expected).

Fields of papers citing papers by Xianghou Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianghou Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianghou Xia. The network helps show where Xianghou Xia may publish in the future.

Co-authorship network of co-authors of Xianghou Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Xianghou Xia. A scholar is included among the top collaborators of Xianghou Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianghou Xia. Xianghou Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Qin, Chengdong, Siyuan Liu, Shiqi Zhou, et al.. (2023). Tanshinone IIA promotes vascular normalization and boosts Sorafenib’s anti-hepatoma activity via modulating the PI3K-AKT pathway. Frontiers in Pharmacology. 14. 1189532–1189532. 9 indexed citations
2.
Qin, Chengdong, Siyuan Liu, Xianghou Xia, et al.. (2023). PIK3C2A is a prognostic biomarker that is linked to immune infiltrates in kidney renal clear cell carcinoma. Frontiers in Immunology. 14. 1114572–1114572. 3 indexed citations
3.
Deng, Yalan, Xianghou Xia, Yang Zhao, et al.. (2021). Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance. Nature Communications. 12(1). 7041–7041. 84 indexed citations
4.
Xia, Xianghou, et al.. (2021). Dissection of Level III Axillary Lymph Nodes in Breast Cancer. Cancer Management and Research. Volume 13. 2041–2046. 5 indexed citations
5.
6.
Xia, Xianghou, Wenjuan Yin, Jiefei Mao, et al.. (2021). Gasdermin D as a potential prognosis and treatment response prediction biomarker for invasive breast cancer.. Journal of Clinical Oncology. 39(15_suppl). e12548–e12548. 3 indexed citations
7.
Xia, Xianghou, Yang Yu, Hongjian Yang, et al.. (2021). Gasdermin C as a potential prognostic biomarker and its correlation with immune infiltration in pancreatic ductal adenocarcinoma.. Journal of Clinical Oncology. 39(15_suppl). e16256–e16256. 2 indexed citations
8.
Yin, Wenjuan, Jiaoyue Jin, Canming Wang, Dan Su, & Xianghou Xia. (2019). Analysis of pathological features of epstein-barr virus-associated gastric cancer and exploration of the role of radical gastrectomy in its clinical prognosis. Zhonghua shiyan waike zazhi. 36(6). 1107–1109. 1 indexed citations
9.
Zhou, Chenhao, Shun Wang, Qiang Zhou, et al.. (2019). A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology. 9. 1160–1160. 17 indexed citations
10.
Yin, Wenjuan, et al.. (2019). The impact of BCL-2/MYC protein expression and gene abnormality on primary central nervous system diffuse large B-cell lymphoma.. PubMed. 12(6). 2215–2223. 10 indexed citations
11.
Wang, Chen, Xianghou Xia, Feng Chen, et al.. (2017). ICT1 knockdown inhibits breast cancer cell growth via induction of cell cycle arrest and apoptosis. International Journal of Molecular Medicine. 39(4). 1037–1045. 11 indexed citations
12.
Zheng, Yurong, et al.. (2017). Breast carcinoma associated with prolactinoma: A case report. Cancer Biology & Therapy. 18(3). 132–136. 6 indexed citations
13.
14.
Chen, Neng, Xianghou Xia, Li‐Qiang Qin, et al.. (2016). Effects of 8-Week Hatha Yoga Training on Metabolic and Inflammatory Markers in Healthy, Female Chinese Subjects: A Randomized Clinical Trial. BioMed Research International. 2016. 1–12. 26 indexed citations
15.
Xia, Xianghou, Wenjuan Yin, Xiping Zhang, et al.. (2015). PAX6 overexpression is associated with the poor prognosis of invasive ductal breast cancer. Oncology Letters. 10(3). 1501–1506. 15 indexed citations
16.
Yang, Hongjian, Yabing Zheng, Xingfei Yu, et al.. (2014). shRNA-mediated silencing of ZFX attenuated the proliferation of breast cancer cells. Cancer Chemotherapy and Pharmacology. 73(3). 569–576. 29 indexed citations
17.
Yang, Hongjian, Xiangming He, Yabing Zheng, et al.. (2014). Down‐Regulation of Asparagine Synthetase Induces Cell Cycle Arrest and Inhibits Cell Proliferation of Breast Cancer. Chemical Biology & Drug Design. 84(5). 578–584. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geriolda Topi Breakdown of academic impact, for papers by Yunhua Lin Breakdown of academic impact, for papers by Shu Tan Breakdown of academic impact, for papers by Tai Ren Breakdown of academic impact, for papers by Christopher Hillard Breakdown of academic impact, for papers by Canqiao Luo Breakdown of academic impact, for papers by Andrew Becker Breakdown of academic impact, for papers by Liangliang Sun Breakdown of academic impact, for papers by Yuying Kou Breakdown of academic impact, for papers by Hillary Dinh
Rankless by CCL
2026